TCM Formula Xiaoyaosan Decoction Improves Depressive-Like Behaviors in Rats with Type 2 Diabetes

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Li, Na ^a   Liu, Qun ^a   Li, Xiao Juan ^a   Bai, Xiao Hui ^a   Liu, Yue Yun ^a   Zhao, Hong Bo ^a   Jin, Zhong Ye ^a   Jing, Yu Xia ^a   Yan, Zhi Yi ^a   Chen, Jia Xu ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; DOPAMINE; EOSIN; FLUOXETINE; GLUCOSE; HEMATOXYLIN; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; SEROTONIN; STREPTOZOCIN; UNCLASSIFIED DRUG; XIAOYAOSAN DECOCTION;

ANGELICA SINENSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ARTICLE; ATRACTYLODES; ATRACTYLODES MACROCEPHALA; BODY WEIGHT; BUPLEURUM CHINENSE; CHRONIC RESTRAINT STRESS; CHRONIC STRESS; CLINICAL EVALUATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG EFFICACY; ETHNOPHARMACOLOGY; EVIDENCE BASED PRACTICE; GINGER; GLUCOSE BLOOD LEVEL; GLYCYRRHIZA URALENSIS; HERBAL MEDICINE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMOBILIZATION STRESS; INSULIN TOLERANCE TEST; LIPID DIET; LOCOMOTION; MALE; MENTHA; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PAEONIA LACTIFLORA; PORIA COCOS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; RAT; STAINING; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84945583330     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/415243     Document Type: Article

References (38)

1. R. D. Goldney, P. J. Phillips, L. J. Fisher, and D. H. Wilson, "Diabetes, depression, and quality of life: a population study," Diabetes Care, vol. 27, no. 5, pp. 1066-1070, 2004.
2. P. J. Lustman, R. J. Anderson, K. E. Freedland, M. de Groot, R. M. Carney, and R. E. Clouse, "Depression and poor glycemic control: a meta-analytic review of the literature," Diabetes Care, vol. 23, no. 7, pp. 934-942, 2000.
3. J. S. Gonzalez, S. A. Safren, E. Cagliero et al., "Depression, selfcare, and medication adherence in type 2 diabetes: relationships across the full range of symptomseverity," Diabetes Care, vol. 30, no. 9, pp. 2222-2227, 2007.
4. N. Hutter, A. Schnurr, and H. Baumeister, "Healthcare costs in patients with diabetes mellitus and comorbid mental disorders-a systematic review," Diabetologia, vol. 53, no. 12, pp. 2470-2479, 2010.
5. C. Li, E. S. Ford, G. Zhao, L. S. Balluz, J. T. Berry, and A. H. Mokdad, "Undertreatment of mental health problems in adults with diagnosed diabetes and serious psychological distress: the behavioral risk factor surveillance system, 2007," Diabetes Care, vol. 33, no. 5, pp. 1061-1064, 2010.
6. R. J. Anderson, K. E. Freedland, R. E. Clouse, and P. J. Lustman, "The prevalence of comorbid depression in adultswith diabetes: a meta-analysis," Diabetes Care, vol. 24, no. 6, pp. 1069-1078, 2001.
7. S. Ali, M. A. Stone, J. L. Peters, M. J. Davies, and K. Khunti, "The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis," Diabetic Medicine, vol. 23, no. 11, pp. 1165-1173, 2006.
8. S. Sarkar and Y. P. Balhara, "Diabetes mellitus and suicide," Indian Journal of Endocrinology and Metabolism, vol. 18, no. 4, pp. 468-474, 2014.
9. M. T. Li and H. Xiang, "Advances in effective ingredients and pharmacological action of Xiaoyao Pill or Xiaoyao San research," Journal of ChineseMedicinalMaterials, vol. 33, no. 12, pp. 1968-1972, 2010.
10. D. R. Gehlert, "Role of hypothalamic neuropeptide Y in feeding and obesity," Neuropeptides, vol. 33, no. 5, pp. 329-338, 1999.
11. A. Sainsbury, F. Rohner-Jeanrenaud, E. Grouzmann, and B. Jeanrenaud, "Acute intracerebroventri-cular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats," Neuroendocrinology, vol. 63, no. 4, pp. 318-326, 1996.
12. J. Liu, Y. Zhang, M. Han, Z. Liu, J. Wang, and Q. He, "Chinese herbal formula Xiao Yao San for treatment of depression: a systematic review of randomized controlled trials," Evidencebased Complementary and Alternative Medicine, vol. 2012, Article ID 931636, 13 pages, 2012.
13. X. K. Qin, P. Li, M. Han, Z. J. Liu, and J.P. Liu, "Systematic review of randomize controlled trials of Xiaoyao Powder in treatment of depression," Journal of Traditional Chinese Medicine, vol. 51, no. 6, pp. 500-505, 2010.
14. B. Ji, J. X. Chen, Z. L. Lu, L. S. Hu, X. Wan, and S. P. Chang, "Investigation of the scope of macroscopic indications related with the syndrome represented by Xiaoyao powder," Journal of Beijing University of Traditional ChineseMedicine, vol. 26, no. 5, pp. 70-73, 2003.
15. H. Ni, G. Liu, and S. Luo, "Clinical study in treating type 2 diabetes mellitus according to liver in TCM," Chinese Journal of Integrated Traditional and Western Medicine, vol. 20, no. 8, pp. 577-579, 2000.
16. X. B. Wang, B. Xie, Z. Y. Zhou et al., "Effects of Danzhi xiaoyao decoction on insulin receptors and insulin receptor substrate- 1 mRNA expression in diabetes mellitus rat with depression," Chinese Journal of Gerontology, vol. 4, no. 7, pp. 1181-1183, 2011.
17. J.-X. Chen, Y.-T. Tang, and J.-X. Yang, "Changes of glucocorticoid receptor and levels of CRFmRNA, POMC mRNA in brain of chronic immobilization stress rats," Cellular and Molecular Neurobiology, vol. 28, no. 2, pp. 237-244, 2008.
18. S.-X. Wang, J.-X. Chen, G.-X. Yue, M.-H. Bai, M.-J. Kou, and Z.- Y. Jin, "Xiaoyaosan decoction regulates changes in neuropeptide y and leptin receptor in the rat arcuate nucleus after chronic immobilization stress," Evidence-Based Complementary and AlternativeMedicine, vol. 2012, Article ID381278, 16pages, 2012.
19. J. X. Chen and Y. T. Tang, "Change of relative brain zone POMC gene expression and effect of Chinese medicine on chronic restrained stress model rats," Chinese Remedies & Clinics, vol. 3, no. 3, pp. 223-226, 2003.
20. J.-X. Chen, W. Li, X. Zhao, and J.-X. Yang, "Effects of the Chinese traditional prescription Xiaoyaosan decoction on chronic immobilization stress-induced changes in behavior and brain BDNF, TrkB, and NT-3 in rats," Cellular and Molecular Neurobiology, vol. 28, no. 5, pp. 745-755, 2008.
21. R. S. Duman, G. R. Heninger, and E. J. Nestler, "Amolecular and cellular theory of depression," Archives of General Psychiatry, vol. 54, no. 7, pp. 597-606, 1997.
22. Q.-Q. Mao, S.-P. Ip, K.-M. Ko, S.-H. Tsai, Y.-F. Xian, and C.-T. Che, "Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity," Journal of Ethnopharmacology, vol. 124, no. 2, pp. 316-320, 2009.
23. Y. Xu, B. S. Ku, H. Y. Yao et al., "Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats," Pharmacology Biochemistry and Behavior, vol. 82, no. 1, pp. 200-206, 2005.
24. F. M. Qiu, X. M. Zhong, Q. Q. Mao, and Z. Huang, "The antidepressant- like effects of paeoniflorin in mouse models," Experimental and TherapeuticMedicine, vol. 5, no. 4, pp. 1113-1116, 2013.
25. W.-S. Wu, "ERK signaling pathway is involved in p15INK4b/ p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a," Oncogene, vol. 22, no. 7, pp. 955-963, 2003.
26. Z. Zhao, W. Wang, H. Guo, and D. Zhou, "Antidepressantlike effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats," Behavioural Brain Research, vol. 194, no. 1, pp. 108-113, 2008.
27. M. Miao, B. Cheng, and M. Li, "Effect of curcumin on diabetic ratmodel of cerebral ischemia," Pakistan Journal of Pharmaceutical Sciences, vol. 28, no. 1, pp. 401-405, 2015.
28. J. Fu, Y. Li, L. Wang, B. Gao, N. Zhang, and Q. Ji, "Paeoniflorin prevents diabetic nephropathy in rats," Comparative Medicine, vol. 59, no. 6, pp. 557-566, 2009.
29. K. Rashid and P. C. Sil, "Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats," Toxicology and Applied Pharmacology, vol. 282, no. 3, pp. 297-310, 2015.
30. R. Afrin, S. Arumugam, V. Soetikno et al., "Curcumin ameliorates streptozotocin-induced liver damage throughmodulation of endoplasmic reticulumstress-mediated apoptosis in diabetic rats," Free Radical Research, vol. 49, no. 3, pp. 279-289, 2015.
31. E. Blomstrand, "A role for branched-chain amino acids in reducing central fatigue," Journal of Nutrition, vol. 136, no. 2, pp. 544S-547S, 2006.
32. V. Lozeva-Thomas, "Serotonin brain circuits with a focus on hepatic encephalopathy," Metabolic Brain Disease, vol. 19, no. 3-4, pp. 413-420, 2004.
33. J.N. Crawley, "Exploratory behavior models of anxiety in mice," Neuroscience & Biobehavioral Reviews, vol. 9, no. 1, pp. 37-44, 1985.
34. M. Maroun and G. Richter-Levin, "Exposure to acute stress blocks the induction of long-termpotentiation of the amygdalaprefrontal cortex pathway in vivo," The Journal of Neuroscience, vol. 23, no. 11, pp. 4406-4409, 2003.
35. B. S. McEwen, "Glucocorticoids, depression, and mood disorders: structural remodeling in the brain," Metabolism, vol. 54, no. 5, pp. 20-23, 2005.
36. P. Maheux, F. Ducros, J. Bourque, J. Garon, and J.-L. Chiasson, "Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetesmellitus independently of weight loss," International Journal of Obesity, vol. 21, no. 2, pp. 97-102, 1997.
37. V. M. Connolly, A. Gallagher, and C. M. Kesson, "A study of fluoxetine in obese elderly patients with type 2 diabetes," Diabetic Medicine, vol. 12, no. 5, pp. 416-418, 1995.
38. R. S. Surwit, M. A. L. Van Tilburg, N. Zucker et al., "Stress management improves long-term glycemic control in type 2 diabetes," Diabetes Care, vol. 25, no. 1, pp. 30-34, 2002.